Insmed (INSM) Treasury Shares (2011 - 2026)

Insmed's (INSM) quarterly Treasury Shares came in at $92219.0 in Q1 2026, down 97.63% quarter-over-quarter from $3.9 million in Q4 2025.

Insmed (INSM) Treasury Shares (2011 - 2026) Analysis & Trends

Insmed's Treasury Shares history runs 16 years deep, the most recent figure standing at $92219.0 for Q1 2026.

  • On a quarterly basis, Treasury Shares changed N/A year-over-year to $92219.0 in Q1 2026; TTM through Mar 2026 was $92219.0, a N/A change from a year earlier, with the FY2025 full-year figure at $3.9 million, up 17.13% from the prior year.
  • Treasury Shares slipped to $92219.0 in Q1 2026 per INSM's latest filing, from $3.9 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $3.9 million in Q4 2025 and bottomed at $92219.0 in Q1 2026.
  • The 5-year median for Treasury Shares is $266550.0 (2023), against an average of $1.3 million.
  • Across the five-year window, Treasury Shares surged 80.95% in 2023 and slipped 0.25% in 2024, its largest moves.
  • Year by year, Treasury Shares stood at $1.5 million in 2022, then soared by 80.95% to $2.8 million in 2023, then rose by 20.73% to $3.3 million in 2024, then climbed by 17.13% to $3.9 million in 2025, then plunged by 97.63% to $92219.0 in 2026.
  • Per Business Quant, the three latest INSM Treasury Shares figures stand at $92219.0 (Q1 2026), $3.9 million (Q4 2025), and $3.3 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -21,709.08
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 265,401.92
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 19.41 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 5.14 Mn
10 Insmed 23.26 Bn 22.03 Bn 258.54 Mn 92,219.00

Historic Data

Download Data
DateValue
Mar 31, 2026 92,219.00
Mar 31, 2026 92,219.00
Dec 31, 2025 3.89 Mn
Dec 31, 2025 3.89 Mn
Dec 31, 2024 3.32 Mn
Dec 31, 2024 3.32 Mn
Sep 30, 2024 265,887.00
Sep 30, 2024 265,887.00
Jun 30, 2024 265,887.00
Jun 30, 2024 265,887.00
Mar 31, 2024 266,550.00
Mar 31, 2024 266,550.00
Dec 31, 2023 2.75 Mn
Dec 31, 2023 2.75 Mn
Sep 30, 2023 266,550.00
Sep 30, 2023 266,550.00
Jun 30, 2023 266,550.00
Jun 30, 2023 266,550.00
Dec 31, 2022 1.52 Mn
Dec 31, 2022 1.52 Mn